Global Minimally Invasive VCF Devices Market Report

News provided by

Research and Markets

14 Apr, 2014, 12:40 GMT

DUBLIN, Apr. 14, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/n4bj2c/global_minimally) has announced the addition of the "Global Minimally Invasive VCF Devices Market Report" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The analysts forecast the Global Minimally Invasive VCF Devices market to grow at a CAGR of 10.12 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of osteoporosis. The Global Minimally Invasive VCF Devices market has also been witnessing an increased focus on reduced risk of cement leakage by vendors. However, the high cost of VCF surgeries could pose a challenge to the growth of this market.

The report, Global Minimally Invasive VCF Devices Market Report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Minimally Invasive VCF Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Companies are also focusing on reducing the risks associated with the VCF treatments during and after surgery. Thus, they are coming up with advanced equipment which reduces the risk of cement leakage during surgery. Further, as a result of the latest innovations in VCF products, the risk in the vertebroplasty procedure is getting reduced. Furthermore, the quality of the balloons introduced during the kyphoplasty procedure is also being improved so as to reduce the leakage of the cement inserted inside them during the surgery.

According to the report, one of the major growth factors driving the Global Minimally Invasive VCF Devices market is the increasing incidence of osteoporosis. About 85 percent of the VCF cases are due to osteoporosis.

Further, the report states that , most VCF treatments are expensive for patients in developing nations. Kyphoplasty treatments are much more expensive than vertebroplasty treatments, which could affect the future growth of the Global Minimally Invasive VCF Devices market. Moreover, the high price of these treatments is also due to the monopolistic approach in this market, where Medtronic has acquired almost 80-82 percent of the market share. Hence, this market lacks competitive pricing.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.


Key Topics Covered:

1. Executive Summary

2. Scope of the Report

3. Market Research Methodology

4. List of Abbreviations

5. Introduction

6. Market Landscape

7. Market Segmentation by Technology

8. Complications Associated with Vertebroplasty and Kyphoplasty

9. Geographical Segmentation

10. Key Leading Countries

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

20. Other Reports in this Series


Companies Mentioned:

  • Alphatec Spine Inc.
  • AOI Medical Inc.
  • Benvenue Medical Inc.
  • Biomet Inc.
  • Bonesupport AB
  • Carefusion Corp.
  • Cook Medical Inc.
  • Crosstrees Medical Inc.
  • De Puy Spine Inc.
  • Medtronic Inc.
  • Stryker Corp.
  • Zimmer Holdings Inc.


For more information visit http://www.researchandmarkets.com/research/n4bj2c/global_minimally


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net